Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1994 1
2000 3
2004 2
2006 3
2007 4
2014 2
2015 2
2017 2
2018 4
2019 4
2020 5
2021 3
2022 2
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Oral Orexin Receptor 2 Agonist in Narcolepsy Type 1.
Dauvilliers Y, Mignot E, Del Río Villegas R, Du Y, Hanson E, Inoue Y, Kadali H, Koundourakis E, Meyer S, Rogers R, Scammell TE, Sheikh SI, Swick T, Szakács Z, von Rosenstiel P, Wu J, Zeitz H, Murthy NV, Plazzi G, von Hehn C. Dauvilliers Y, et al. Among authors: szakacs z. N Engl J Med. 2023 Jul 27;389(4):309-321. doi: 10.1056/NEJMoa2301940. N Engl J Med. 2023. PMID: 37494485 Clinical Trial.
Pharmacological management of narcolepsy in children and adolescents.
Plazzi G, Pizza F, Lecendreux M, Gringras P, Barateau L, Bruni O, Franco P, Iranzo A, Jennum P, Khatami R, Knudsen-Heier S, Miano S, Nobili L, Partinen M, Reading P, Sonka K, Szakacs A, Zenti M, Kallweit U, Lammers GJ, Dauvilliers Y, Bassetti CLA. Plazzi G, et al. Among authors: szakacs a. J Sleep Res. 2023 Dec 4:e14055. doi: 10.1111/jsr.14055. Online ahead of print. J Sleep Res. 2023. PMID: 38050449 No abstract available.
Anticancer Thiosemicarbazones: Chemical Properties, Interaction with Iron Metabolism, and Resistance Development.
Heffeter P, Pape VFS, Enyedy ÉA, Keppler BK, Szakacs G, Kowol CR. Heffeter P, et al. Among authors: szakacs g. Antioxid Redox Signal. 2019 Mar 10;30(8):1062-1082. doi: 10.1089/ars.2017.7487. Epub 2018 Feb 26. Antioxid Redox Signal. 2019. PMID: 29334758 Review.
Consequently, in addition to the discussion of physicochemical properties (e.g., complex stability, redox activity), this review contains an overview on the diversity of cellular thiosemicarbazone targets and drug resistance mechanisms....
Consequently, in addition to the discussion of physicochemical properties (e.g., complex stability, redox activity), this review cont …
Hyperthermia induced by transient receptor potential vanilloid-1 (TRPV1) antagonists in human clinical trials: Insights from mathematical modeling and meta-analysis.
Garami A, Shimansky YP, Rumbus Z, Vizin RCL, Farkas N, Hegyi J, Szakacs Z, Solymar M, Csenkey A, Chiche DA, Kapil R, Kyle DJ, Van Horn WD, Hegyi P, Romanovsky AA. Garami A, et al. Among authors: szakacs z. Pharmacol Ther. 2020 Apr;208:107474. doi: 10.1016/j.pharmthera.2020.107474. Epub 2020 Jan 9. Pharmacol Ther. 2020. PMID: 31926897 Free article. Review.
Second-generation (mode-selective) TRPV1 antagonists potently block channel activation by CAP, but exert different effects (e.g., potentiation, no effect, or low-potency inhibition) in the proton mode, heat mode, or both. ...
Second-generation (mode-selective) TRPV1 antagonists potently block channel activation by CAP, but exert different effects (e.g., pot …
Vitamin D supplementation in patients with cystic fibrosis: A systematic review and meta-analysis.
Juhász MF, Varannai O, Németh D, Szakács Z, Kiss S, Izsák VD, Martonosi ÁR, Hegyi P, Párniczky A. Juhász MF, et al. Among authors: szakacs z. J Cyst Fibros. 2021 Sep;20(5):729-736. doi: 10.1016/j.jcf.2020.12.008. Epub 2020 Dec 19. J Cyst Fibros. 2021. PMID: 33349585 Free article.
In this systematic review, we included randomized controlled trials (RCTs) that compared vitamin D supplementation with placebo (i.e. 'non-increased dose') in CF patients. Analysing the 8 included RCTs, the intervention group had significantly higher serum 25-hydroxyvitami …
In this systematic review, we included randomized controlled trials (RCTs) that compared vitamin D supplementation with placebo (i.e. …
Mortality and pathological findings in C (Opitz trigonocephaly) syndrome.
Opitz JM, Putnam AR, Comstock JM, Chin S, Byrne JL, Kennedy A, Frikke MJ, Bernard C, Albrecht S, Der Kaloustian V, Szakacs JG. Opitz JM, et al. Among authors: szakacs jg. Fetal Pediatr Pathol. 2006 Jul-Aug;25(4):211-31. doi: 10.1080/15513810601015753. Fetal Pediatr Pathol. 2006. PMID: 17162528 Review.
In any event, elucidation of cause and pathogenesis of CS will, in due time, shed light on its developmental pleiotropy, rarity in liveborn infants, prevalence in stillborn fetuses, recurrence risk in humans, and occurrence in other animals (e.g., mice) to further understa …
In any event, elucidation of cause and pathogenesis of CS will, in due time, shed light on its developmental pleiotropy, rarity in liveborn …
Identification of New QTLs for Dietary Fiber Content in Aegilops biuncialis.
Ivanizs L, Marcotuli I, Rakszegi M, Kalapos B, Szőke-Pázsi K, Farkas A, Türkösi E, Gaál E, Kruppa K, Kovács P, Darkó É, Szakács É, Said M, Cápal P, Doležel J, Gadaleta A, Molnár I. Ivanizs L, et al. Among authors: szakacs e. Int J Mol Sci. 2022 Mar 30;23(7):3821. doi: 10.3390/ijms23073821. Int J Mol Sci. 2022. PMID: 35409181 Free PMC article.
39 results